Watch experts decode 'The rise of ESG investing' on October 29 at 4pm. Register Now!
Last Updated : Oct 18, 2020 11:59 AM IST | Source: PTI

Earnings data, COVID-19 updates, global trends to drive market this week: Analysts

Rising coronavirus infections in Europe had dented market sentiment last week. Concerns over resurgence in coronavirus cases may also play in investors mind going ahead.


The domestic equity market is likely to be guided by quarterly earnings data, coronavirus-related updates and global trends this week, with bouts of profit-booking at higher levels going ahead, according to analysts.

Rising coronavirus infections in Europe had dented market sentiment last week. Concerns over resurgence in coronavirus cases may also play in investors mind going ahead.

"In absence of any major event, global cues and coronavirus-related updates will remain in focus. Any news of further restrictions due to rise in COVID-19 cases might not go well with markets,” said Ajit Mishra, VP - Research, Religare Broking.


On the earnings front, ACC, Asian Paints, Bajaj Auto, Hindustan Unilever, UltraTech Cement, Bajaj Finance, Bajaj Finserv, Hexaware Technologies and IDBI Bank, among others.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

"Going ahead, market is likely to be in a consolidation mode. Investors would keep a close watch on earnings announcements, rising COVID-19 cases globally, developments around US election. China''s GDP data this week will also be on radar," Siddhartha Khemka, Head - Retail Research, Motilal Oswal Financial Services said.

Over the past week, the Sensex lost 526.51 points or 1.29 per cent.

"We believe markets are in a correction phase due to a quick bounce of the market, to near pre-COVID-19 level. It has brought some volatility, which may stay for some more time. Market will look forward, with high hopes on Q2 results," said Vinod Nair, Head of Research at Geojit Financial Services.

According to Nirali Shah, Senior Research Analyst, Samco Securities, "bourses will be mainly guided by Q2 numbers of marquee names such as HUL to name a few. Investors may also witness profit-booking at higher levels."
First Published on Oct 18, 2020 11:59 am